1298590

Axogen Corporation — FEI 3011006318

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 8, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Burleson, TX (United States)